SUMMARY Absolute serum concentrations of pregnancy-associated a2-glycoprotein (a2-PAG) and carcinoembryonic antigen (CEA) were compared in 54 patients before and after surgery for colorectal cancer. Preoperatively, elevated levels of a2-PAG were found in 32 (59 %) and of CEA in 35 (65 %). Postoperatively, elevated a2-PAG levels were found in 10 of 18 patients (56%) without clinical evidence of recurrence whereas elevated CEA levels were present in three (16 %). In patients who developed clinical evidence of tumour recurrence, a2-PAG levels were elevated in 8 of 13 (62 %) while CEA levels were uniformly abnormal. It is concluded that, in this cross-sectional study, measurement of a2-PAG concentrations is less reliable than CEA in the detection of tumour recurrence after apparently curative surgery for colorectal cancer.
Carcinoembryonic antigen (CEA) is well established as a tumour marker in colorectal cancer, particularly in the early detection of tumour recurrence after apparently curative surgery (Holyoke et al., 1972; Mach et al., 1974; Mackay et al., 1974) . Pregnancyassociated a2-glycoprotein (a2-PAG), a high molecular weight serum protein probably produced by circulating leucocytes (Stimson and Blackstock, 1975; Thomson et al., 1978) , occurs in high serum concentrations in pregnancy (Bohn, 1972; Horne et al., 1973) but in only trace amounts in normal individuals . Raised serum a2-PAG concentrations have been reported in several malignant conditions (Horne et al., 1973; Stimson, 1974; Than et al., 1975; Burt et al., 1978) . Further, it has been claimed that elevated a2-PAG levels occur in patients with breast cancer before clinical recognition of recurrent disease (Stimson 1975a and b; Anderson et al., 1976) .
We have shown previously that where serum a2-PAG levels are expressed as a percentage change of the preoperative level, they reflect the clinical course of colorectal cancer (Wood et al., 1978) . In the present cross-sectional study, we have compared critically the value of a2-PAG and CEA Received for publication 10 May 1978 assays as monitors of disease progression in patients with colorectal cancer.
Patients
Fifty-four patients (22 men, 32 women; mean age 59 years; range 30-75 years) with histologically proven large bowel cancer were studied. Serum samples were obtained preoperatively in all cases and at regular intervals in the postoperative period. The follow-up interval was up to 13 months.
Methods
Carcinoembryonic antigen estimations were performed on unextracted serum using a double antibody technique (Laurence et al., 1972) . The upper limit of normal for our laboratory was 25 /ig/l (Wood et al., 1976) . Values were referred to a purified CEA preparation provided by Professor A. M. Neville. Pregnancy-associated a2-glycoprotein estimations were performed on unextracted serum by an electroimmunoassay technique modified (Bohn, 1972) from that described by Laurell (1966) . The upper limit of normal for men was Wood et al.
by age 75 years (MacMillan et al., 1977, unpublished data) . Levels greater than 60 mg/l in women were taken to be elevated in this study. A standard reference preparation of a2-PAG was provided by Dr H. Bohn, Behringwerke AG, West Germany.
Results
Preoperatively (Table 1 ) elevated a2-PAG levels were found in 32 patients (59%) and elevated CEA levels in 35 (65 %). In patients in whom curative surgery was not possible due to extensive local tumour spread or metastases, elevated levels of a2-PAG occurred in 16 of 23 (70 %), and elevated CEA in 18 of 23 (78 %). In patients who underwent 'curative' resection, a2-PAG was elevated preoperatively in 16 of 31 (52 %) and CEA in 17 of 31 (55%). Marker levels during the 13-month postoperative period are compared in Table 2 . The analysis includes the last recorded results in four patients with distant metastases who died within this period. Ten of 18 patients (56%) who had undergone 'curative' surgery and who remained apparently free of tumour showed elevated a2-PAG levels, whereas only three (16%) showed elevated CEA levels. Further investigation of the latter patients failed to reveal occult tumour. Of the 13 patients who had developed clinical signs of tumour recurrence, eight (62 %) had elevated a2-PAG levels while CEA levels were uniformly elevated. All the 10 patients with extensive tumour spread at operation had elevated CEA levels and eight had elevated Table 3 analyses the temporal pattern of marker levels in the 13 patients with tumour recurrence after 'curative' surgery. All patients had elevated CEA levels; in five, levels became abnormal before clinical detection of tumour recurrence, while in the other patients, CEA levels never returned to normal after surgery. Eight patients (62%) showed elevated a2-PAG levels; in three patients levels became abnormal though normal preoperatively. In only one of these did a2-PAG levels rise before CEA. In five patients with elevated preoperative levels a2-PAG remained persistently elevated.
Discussion
The role of pregnancy-associated a2-PAG as a tumour marker has not been fully assessed. Increased serum concentrations of a2-PAG have been noted during the clinical course of malignant diseases (Horne et al., 1973; Stimson, 1975a and b; Than et al., 1975; Wood et al., 1978) but this finding is disputed by other groups Burnett et al., 1977) .
The purpose of the present study was to compare the clinical value of measurement of absolute concentrations of a2-PAG and CEA in the same patients with colorectal cancer, taking into account the age and sex relatedness of a2-PAG values MacMillan et al., 1977, unpublished data). Preoperatively, a similar proportion of patients showed elevated marker levels. Postoperatively, CEA assays were clearly superior in indicating tumour burden and in predicting tumour recurrence alter 'curative' surgery. a2-PAG assays were frequently falsely positive, 53 % of patients showing elevated values in the absence of clinical evidence of tumour recurrence up to 13 months after operation. Only 16 % of these patients had elevated CEA levels, and these included one patient with a single marginally elevated value (26 ,ug/l). All patients with tumour recurrence after 'curative' surgery showed elevated CEA levels whereas a2-PAG was falsely negative in 38%. In patients with residual local tumour or distant metastases, the proportion of patients with elevated a2-PAG levels increased only slightly from 70% preoperatively to 80% after operation whereas all the patients showed elevated CEA levels in the follow-up period.
Although, in longitudinal studies, postoperative changes in a2-PAG levels as related to the preoperative level may give an indication of tumour recurrence (Wood et al., 1978) , the present study clearly shows that measurement of absolute concentrations of a2-PAG is less reliable than that of CEA both in reflecting tumour burden and in the early detection of tumour recurrence after apparently curative surgery for colorectal cancer. 
